4//SEC Filing
Siatis Perry C 4
Accession 0001415889-24-006162
CIK 0001551152other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 5:50 PM ET
Size
8.8 KB
Accession
0001415889-24-006162
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Siatis Perry C
EVP, GC AND SECRETARY
Transactions
- Tax Payment
Common Stock, $0.01 par value
2024-02-28$178.99/sh−7,885$1,411,336→ 20,288 total - Sale
Common Stock, $0.01 par value
2024-02-29$177.05/sh−6,504$1,151,533→ 13,784 total - Sale
Common Stock, $0.01 par value
2024-02-29$178.04/sh−3,387$603,021→ 10,397 total
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.51 to $177.43, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 1, 2023.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.51 to $177.88, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001951400
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 5:50 PM ET
- Size
- 8.8 KB